Key2Compliance
10
0
1
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 10 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
A Post-market-clinical Follow-up Investigation of Safety and Performance by Decoria® Intense Strong
Role: collaborator
Clinical Investigation on Lips Treated With HA-filler
Role: collaborator
A Post-market-clinical Follow-up Investigation of Safety and Performance by Decoria® Voluma
Role: collaborator
A Clinical Investigation of MINIVISC® PLUS 14 mg/ml Fermented Ophthalmic Viscosurgical Device (OVD-F), Used for Cataract Surgery and Implantation of Intraocular Lenses, Glaucoma Surgery, Anterior Segment Surgery and Corneal Transplantation (CGAC)
Role: collaborator
Clinical Investigation of the Multi4 System
Role: collaborator
First-in-human Single and Multiple Dose Trial of ATR-258
Role: collaborator
A User Study With Vernivia® for Bacterial Vaginosis.
Role: collaborator
Efficacy and Safety of D005 Vaginal Mousse on Bacterial Vaginosis
Role: collaborator
Clinical Investigation to Assess the Feasibility of a New Diabetes Management Program
Role: collaborator
Investigation to Evaluate Safety and Efficacy of the Endodrill Model X Biopsy Instrument
Role: collaborator
All 10 trials loaded